NASDAQ · OFIX
Orthofix Medical Inc.
Healthcare · Medical - Devices
$9.44▲ 3.06% ($0.28)at close
As of 4:00 PM ET
Market cap
$381.58M
P/E
Valuation
Revenue & margin DCF
A cash-flow estimate wouldn't be reliable here
More than 85% of this valuation sits in the terminal value beyond year 10, so the result is driven by the perpetuity assumption rather than the projected decade. The valuation is not shown.
Price vs. estimate range
Assumption scenarios, not confidence intervals
Bull $29.82; price used $9.44
Bull $29.82; price used $9.44
- 10-yr revenue CAGR
- 5.6%
- Ending operating margin
- 0.0%
- Discount rate
- 8.5%
USD · TTM ending Jun 30, 2026 · Price used $9.44 · Price Sep 25, 8:00 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 34.35% over the last year. Revenue grew 2.99% over the trailing twelve months. Operating margin moved from -11.77% to -3.05%.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price, and the shares now sit around the 0th percentile of their historical P/E range. That looks more like a rerating of the multiple than a collapse in the business.
What would invalidate this read
This read changes if operating margin (currently -3.05%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Return analysis
Company profile
Orthofix Medical Inc., founded in 1980 and headquartered in Lewisville, Texas, operates as a global medical technology company focusing on devices and biologics.
Market multiples
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
8
Buy
9
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 3, 2026
Q4 FY26 · EPS est $0.11 · Revenue est $210.69M
View
Institutional Sentiment
Orthofix Medical Inc. · OFIX
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.